Anbio Biotechnology (NNNN) Surges 142% in 2025
Anbio Biotechnology Inc. (NASDAQ:NNNN) has quickly become one of the most closely watched small-cap biotech stocks on Wall…
Why Glaukos (GKOS) Could Surge 30% in 2025
Glaukos Corporation (NYSE:GKOS) remains one of the most innovative and disruptive players in the ophthalmic medical technology sector,…
Pfizer vs Novo Nordisk: The $10B War Over Metsera (MTSR)
Metsera Inc. (NASDAQ: MTSR) is a next-generation biotechnology company pioneering innovative therapies for obesity and metabolic diseases through…
Immuron (IMRN) Raises $8.5M for Biotech Expansion
Immuron Limited (NASDAQ:IMRN) is an Australia-based biopharmaceutical company focused on developing and commercializing innovative oral immunotherapies that target…
ImageneBio (IMA) Targets 3,634% Upside
ImageneBio Inc. (NASDAQ:IMA) is a clinical-stage biopharmaceutical company dedicated to developing next-generation therapies for immunological and inflammatory diseases…
4D Molecular Therapeutics (FDMT) Price Target Signals 176% Upside
4D Molecular Therapeutics Inc. (NASDAQ:FDMT) is a clinical-stage biopharmaceutical company pioneering a new generation of genetic medicines through…
Neumora Therapeutics (NMRA) Backed by Amgen with 22% Stake
Neumora Therapeutics Inc. (NASDAQ:NMRA) is a clinical-stage biotechnology company singularly focused on transforming the treatment of brain diseases…
Euda Health (EUDA) Launches Strategic India Partnership
Euda Health Holdings Limited (NASDAQ:EUDA) is a Singapore-based healthcare technology company focused on transforming the delivery of preventive…
Kyverna (KYTX) Could Become the 1st $10B Autoimmune CAR T Company
Kyverna Therapeutics Inc. (NASDAQ:KYTX) is a clinical-stage biopharmaceutical company focused on transforming the treatment paradigm for autoimmune diseases…
Creative Medical (CELZ) Narrows Loss by 21% and Shares Jump 14%
Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) is a clinical-stage biotechnology company pioneering breakthrough regenerative medicine and cell-based technologies…
Gossamer Bio (GOSS) Targets $7 Billion PAH Market
Gossamer Bio Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company founded with a mission to develop breakthrough therapies targeting…
Clover Health (CLOV) Surges 19% After Buy Rating
Clover Health Investments Corp. (NASDAQ:CLOV) is a next-generation health technology company transforming the U.S. healthcare system through its…
180 Life Sciences (ATNF) Acquires 82K ETH After $425M Raise
180 Life Sciences Corp. (NASDAQ:ATNF) is a formerly clinical-stage biotechnology company that has strategically transformed its business model…
Syndax (SNDX) Surges 40.5% in 3 Months
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a clinical and now commercial-stage biopharmaceutical company committed to developing and delivering transformative…
Armata Pharma (ARMP) Skyrockets 103% in One Day
Armata Pharmaceuticals Inc. (NYSE:ARMP) is a clinical-stage biotechnology company focused on pioneering bacteriophage-based therapeutics, a groundbreaking approach to…
Genprex (GNPX) Raises $2.7M to Accelerate FDA Fast Track Trials
Genprex Inc. (NASDAQ:GNPX) is a clinical-stage gene therapy company headquartered in Austin, Texas, focused on developing transformative, potentially…
Hedge Funds Are Quietly Loading Up on Neuphoria (NEUP)
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) is a clinical-stage biotechnology company focused on developing next-generation treatments for neuropsychiatric disorders through…
Genenta Science (GNTA) Surges 91%!!!
Genenta Science S.p.A. (NASDAQ:GNTA) is a clinical-stage biotechnology company headquartered in Milan, Italy, pioneering a breakthrough approach to…